Ace Therapeutics is an expert in the field of liver disease drug development. We aim to provide the most professional research services to liver disease drug development investigators worldwide.
With the advancement of science and technology and the continuous attention and research on stellate cells, scientists have uncovered more and more mysteries about stellate cells. In view of the important regulatory role played by hepatic stellate cells in the pathology of liver disease, we offer a range of services to target stellate cells for the development of drugs for liver disease.
Stellate cells, especially hepatic stellate cells, play an important regulatory role in the development of liver disease. Therefore, based on our rich research experience and advanced technology platform, we provide comprehensive drug development services for liver diseases targeting stellate cells.
Given that the liver is the only solid organ capable of maintaining a stable organ-to-body weight ratio using regenerative mechanisms to restore homeostasis in the body after injury, we should take full advantage of the liver's regenerative mechanisms to restore its function when developing drugs to treat liver disease.
Stellate cells are important mediators of hepatic immunomodulation, which induce a variety of immune cells to regulate inflammation. In view of this, we offer well-established services for developing liver disease drugs targeting the immunomodulatory effects of stellate cells.
Ace Therapeutics has extensive research experience in the field of liver disease drug development. Our team is committed to providing you with the most professional and scientific liver disease drug development services. If you have any comments or questions, please contact us so we can help you better.
Our products and services are for research use only and can not be used for diagnostic or other purposes.